Stabilitech raises £3.3 million for stabilising pharmaceuticals and vaccines
This article was originally published in Scrip
Executive Summary
Stabilitech, a private UK company, has raised £3.3 million to advance its proprietary thermal stablilisation technology for vaccines and biopharmaceuticals.